Tuesday 21 10 08
Data presented today at the United European Gastroenterology Week Congress (UEGW) show that a significantly greater proportion of patients with moderate to severe Crohn's disease experienced steroid-free remission and mucosal healing when receiving Remicade(R) (infliximab), either in combination with azathioprine or as monotherapy, compared to patients receiving azathioprine alone...... |
Monday 20 10 08
To help those with inflammatory bowel disease (IBD) be better informed and involved in managing their disease, the European Foundation of Crohn's & Ulcerative Colitis Associations (EFCCA) has launched a new series of guides titled "Life and IBD". For over one million people across Europe who have it, IBD can be an overwhelming experience with new physicians, medications and terminology...... |
Thursday 16 10 08
Oct 16, 2008 - Research and Markets has announced the addition of the "Commercial Insight: Inflammatory Bowel Disease - Convenience and Compliance Drive Market Success" report to their offering. ..... |
Wednesday 15 10 08
Title: IBD, Liver Disease Patients Show Vitamin D Deficits
Category: Health News
Created: 10/15/2008 2:00:00 AM
Last Editorial Review: 10/15/2008..... |
Thursday 09 10 08
Salix Pharmaceuticals, Ltd. today announced that 1.5 g mesalamine granules once-daily maintained remission versus placebo in ulcerative colitis patients who switched from another 5-ASA product Additional ... ..... |
Monday 01 09 08
 Scientists have discovered two new genes that increase the risk of developing inflammatory bowel disease (IBD) in childhood. While further study is needed to identify the specific disease-causing mutations in these new genes, the scientists say the genes are especially ..... |
Saturday 02 08 08
NEW YORK (Reuters Health) - Children who grow up in a spic-and-span home may have a higher risk of developing inflammatory bowel disease, a study suggests.
|
Friday 18 07 08
When Tracy Habenicht decided to write about her friend Keith Means' struggle with ulcerative colitis , she chose not to concentrate on the challenges of the disease, but rather how each little improvement was ... ..... |
Wednesday 16 07 08
Physician-scientists from NewYork-Presbyterian/Weill Cornell, involved in clinical trials for a new drug for those who suffer from inflammatory bowel disease (IBD), say it is the best option among available drugs. Gaizo is a reformulation of the active ingredient 5-ASA in currently available drugs. However, the researchers found that 99 percent of the active ingredient in the new pill is released..... |
Wednesday 16 07 08
Betsy Arnold feels she may be at the end of treatment options for the ulcerative colitis she has suffered from for 15 years. ..... |
Bookmark with: